HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Alpha 1-antitrypsin deficiency: a review with special reference to the significance of heterozygous deficiency].

Abstract
Homozygous deficiency of alpha-1 antitrypsin is the most common inborn error or metabolism in Europe. Severe deficiency of this major protease inhibitor in serum is associated with chronic obstructive lung disease, chronic liver disease in adults and neonatal hepatitis. An overview is given of the role of heredity, and the diagnostic criteria and clinical and histological findings in this disorder. Emphysema seems to be caused by the free elastolytic activity of white cells, leading to the degradation of elastin. The pathophysiology of liver disease - less well understood - is discussed with special emphasis on the importance of heterozygous alpha-1 antitrypsin deficiency. Exogenous noxae seem to play an important role in the pathogenesis of heterozygous deficiency. In view of the 7% frequency of heterozygous alpha-1 antitrypsin deficiency in the European population and the role of noxae in the development of pulmonary and liver diseases, improved prophylaxis is mandatory.
AuthorsM Schneider, G Pott, U Gerlach
JournalKlinische Wochenschrift (Klin Wochenschr) Vol. 64 Issue 5 Pg. 197-205 (Mar 03 1986) ISSN: 0023-2173 [Print] Germany
Vernacular TitleAlpha-1-Antitrypsin-Mangel. Eine Ubersicht unter besonderer Berücksichtigung der Bedeutung des heterozygoten Mangels.
PMID3009960 (Publication Type: English Abstract, Journal Article)
Chemical References
  • alpha 1-Antitrypsin
Topics
  • Adult
  • Alleles
  • Carcinoma, Hepatocellular (genetics)
  • Child
  • Genes, Dominant
  • Heterozygote
  • Homozygote
  • Humans
  • Liver Diseases (genetics)
  • Liver Neoplasms (enzymology)
  • Phenotype
  • Prognosis
  • Pulmonary Emphysema (genetics)
  • alpha 1-Antitrypsin (genetics)
  • alpha 1-Antitrypsin Deficiency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: